ALLIANCEBERNSTEIN L.P. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$75,192,096
-26.2%
1,497,254
-7.1%
0.03%
-23.8%
Q2 2023$101,826,639
+29.9%
1,611,181
-7.5%
0.04%
+23.5%
Q1 2023$78,363,762
+16.4%
1,741,804
+13.4%
0.03%
+13.3%
Q4 2022$67,298,951
-27.5%
1,536,155
+9.0%
0.03%
-33.3%
Q3 2022$92,846,000
+22.8%
1,409,107
-5.9%
0.04%
+28.6%
Q2 2022$75,634,000
-21.6%
1,497,405
-0.9%
0.04%
-5.4%
Q1 2022$96,522,000
-40.0%
1,510,991
+0.7%
0.04%
-35.1%
Q4 2021$160,745,000
+12.1%
1,500,745
+7.6%
0.06%0.0%
Q3 2021$143,338,000
+16.2%
1,394,204
-0.6%
0.06%
+14.0%
Q2 2021$123,341,000
-9.3%
1,402,239
+0.2%
0.05%
-16.7%
Q1 2021$136,061,000
-5.9%
1,399,369
+8.6%
0.06%
-11.8%
Q4 2020$144,539,000
+17.9%
1,288,805
-2.6%
0.07%
+3.0%
Q3 2020$122,625,000
+34.3%
1,322,813
+13.0%
0.07%
+22.2%
Q2 2020$91,324,000
+43.9%
1,170,824
+7.9%
0.05%
+17.4%
Q1 2020$63,471,000
-29.5%
1,085,347
-3.5%
0.05%
-9.8%
Q4 2019$90,082,000
+15.4%
1,124,473
+5.8%
0.05%
+4.1%
Q3 2019$78,063,000
-20.5%
1,062,518
+2.0%
0.05%
-19.7%
Q2 2019$98,232,000
+23.7%
1,041,370
+5.0%
0.06%
+17.3%
Q1 2019$79,420,000
+69.6%
992,129
+14.2%
0.05%
+48.6%
Q4 2018$46,841,000
-41.6%
868,870
-15.4%
0.04%
-32.7%
Q3 2018$80,154,000
+63.0%
1,026,822
+32.5%
0.05%
+52.9%
Q2 2018$49,184,000
-33.5%
774,794
-3.9%
0.03%
-35.8%
Q1 2018$73,959,000
+12.8%
806,527
-7.3%
0.05%
+12.8%
Q4 2017$65,589,000
-12.3%
869,767
-19.0%
0.05%
-16.1%
Q3 2017$74,830,000
+37.4%
1,074,063
-0.1%
0.06%
+33.3%
Q2 2017$54,451,000
+40.0%
1,074,629
+10.5%
0.04%
+35.5%
Q1 2017$38,898,000
+5093.3%
972,699
+3543.1%
0.03%
+3000.0%
Q4 2016$749,000
-5.5%
26,7000.0%0.00%0.0%
Q3 2016$793,000
+116.1%
26,700
+47.5%
0.00%
Q2 2016$367,000
+24.0%
18,100
+10.4%
0.00%
Q1 2016$296,000
-45.5%
16,400
-20.4%
0.00%
Q4 2015$543,000
+65.0%
20,600
+33.8%
0.00%
Q3 2015$329,000
-13.2%
15,400
+7.7%
0.00%
Q2 2015$379,00014,3000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders